STC
CLDX icon

SEI Trust Company’s Celldex Therapeutics CLDX Stock Holding History

SEI Trust Company’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$252K Buy
1,295
+38
+3% +$8.28K ﹤0.01% 1258
2014
Q2 		$308K Buy
+1,257
New +$284K ﹤0.01% 1217
2013
Q3 		– Sell
-2,247
Closed -$526K – 1550
2013
Q2 		$526K Buy
+2,247
New +$442K 0.01% 900

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SEI Trust Company's CLDX Position: Q3 2014 in Review

SEI Trust Company increased its Celldex Therapeutics (CLDX) stake by 3% in Q3 2014, buying an estimated $8.28K and bringing the position to 1,295 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #1258.

SEI Trust Company first reported a position in CLDX in Q2 2013 and has held it in 3 quarters since. The position peaked at $526K in Q2 2013. 148 funds tracked by Wall St. Rank hold CLDX as of Q3 2014.

  • SEI Trust Company held 1,295 shares of Celldex Therapeutics worth $252K as of Q3 2014.
  • SEI Trust Company bought 38 Celldex Therapeutics shares in Q3 2014, an estimated $8.28K.
  • Celldex Therapeutics made up ﹤0.01% of SEI Trust Company's portfolio in Q3 2014, its #1258 holding.
  • SEI Trust Company first reported a position in Celldex Therapeutics in Q2 2013 and has held it in 3 quarters since.
  • SEI Trust Company's Celldex Therapeutics position peaked at $526K in Q2 2013.
  • 148 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.